Cargando…

First case of postmortem study in a patient vaccinated against SARS-CoV-2

A previously symptomless 86-year-old man received the first dose of the BNT162b2 mRNA COVID-19 vaccine. He died 4 weeks later from acute renal and respiratory failure. Although he did not present with any COVID-19-specific symptoms, he tested positive for SARS-CoV-2 before he died. Spike protein (S1...

Descripción completa

Detalles Bibliográficos
Autores principales: Hansen, Torsten, Titze, Ulf, Kulamadayil-Heidenreich, Nidhi Su Ann, Glombitza, Sabine, Tebbe, Johannes Josef, Röcken, Christoph, Schulz, Birte, Weise, Michael, Wilkens, Ludwig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051011/
https://www.ncbi.nlm.nih.gov/pubmed/33872783
http://dx.doi.org/10.1016/j.ijid.2021.04.053
_version_ 1783679679506415616
author Hansen, Torsten
Titze, Ulf
Kulamadayil-Heidenreich, Nidhi Su Ann
Glombitza, Sabine
Tebbe, Johannes Josef
Röcken, Christoph
Schulz, Birte
Weise, Michael
Wilkens, Ludwig
author_facet Hansen, Torsten
Titze, Ulf
Kulamadayil-Heidenreich, Nidhi Su Ann
Glombitza, Sabine
Tebbe, Johannes Josef
Röcken, Christoph
Schulz, Birte
Weise, Michael
Wilkens, Ludwig
author_sort Hansen, Torsten
collection PubMed
description A previously symptomless 86-year-old man received the first dose of the BNT162b2 mRNA COVID-19 vaccine. He died 4 weeks later from acute renal and respiratory failure. Although he did not present with any COVID-19-specific symptoms, he tested positive for SARS-CoV-2 before he died. Spike protein (S1) antigen-binding showed significant levels for immunoglobulin (Ig) G, while nucleocapsid IgG/IgM was not elicited. Acute bronchopneumonia and tubular failure were assigned as the cause of death at autopsy; however, we did not observe any characteristic morphological features of COVID-19. Postmortem molecular mapping by real-time polymerase chain reaction revealed relevant SARS-CoV-2 cycle threshold values in all organs examined (oropharynx, olfactory mucosa, trachea, lungs, heart, kidney and cerebrum) except for the liver and olfactory bulb. These results might suggest that the first vaccination induces immunogenicity but not sterile immunity.
format Online
Article
Text
id pubmed-8051011
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
record_format MEDLINE/PubMed
spelling pubmed-80510112021-04-16 First case of postmortem study in a patient vaccinated against SARS-CoV-2 Hansen, Torsten Titze, Ulf Kulamadayil-Heidenreich, Nidhi Su Ann Glombitza, Sabine Tebbe, Johannes Josef Röcken, Christoph Schulz, Birte Weise, Michael Wilkens, Ludwig Int J Infect Dis Short Communication A previously symptomless 86-year-old man received the first dose of the BNT162b2 mRNA COVID-19 vaccine. He died 4 weeks later from acute renal and respiratory failure. Although he did not present with any COVID-19-specific symptoms, he tested positive for SARS-CoV-2 before he died. Spike protein (S1) antigen-binding showed significant levels for immunoglobulin (Ig) G, while nucleocapsid IgG/IgM was not elicited. Acute bronchopneumonia and tubular failure were assigned as the cause of death at autopsy; however, we did not observe any characteristic morphological features of COVID-19. Postmortem molecular mapping by real-time polymerase chain reaction revealed relevant SARS-CoV-2 cycle threshold values in all organs examined (oropharynx, olfactory mucosa, trachea, lungs, heart, kidney and cerebrum) except for the liver and olfactory bulb. These results might suggest that the first vaccination induces immunogenicity but not sterile immunity. The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021-06 2021-04-16 /pmc/articles/PMC8051011/ /pubmed/33872783 http://dx.doi.org/10.1016/j.ijid.2021.04.053 Text en © 2021 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Short Communication
Hansen, Torsten
Titze, Ulf
Kulamadayil-Heidenreich, Nidhi Su Ann
Glombitza, Sabine
Tebbe, Johannes Josef
Röcken, Christoph
Schulz, Birte
Weise, Michael
Wilkens, Ludwig
First case of postmortem study in a patient vaccinated against SARS-CoV-2
title First case of postmortem study in a patient vaccinated against SARS-CoV-2
title_full First case of postmortem study in a patient vaccinated against SARS-CoV-2
title_fullStr First case of postmortem study in a patient vaccinated against SARS-CoV-2
title_full_unstemmed First case of postmortem study in a patient vaccinated against SARS-CoV-2
title_short First case of postmortem study in a patient vaccinated against SARS-CoV-2
title_sort first case of postmortem study in a patient vaccinated against sars-cov-2
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051011/
https://www.ncbi.nlm.nih.gov/pubmed/33872783
http://dx.doi.org/10.1016/j.ijid.2021.04.053
work_keys_str_mv AT hansentorsten firstcaseofpostmortemstudyinapatientvaccinatedagainstsarscov2
AT titzeulf firstcaseofpostmortemstudyinapatientvaccinatedagainstsarscov2
AT kulamadayilheidenreichnidhisuann firstcaseofpostmortemstudyinapatientvaccinatedagainstsarscov2
AT glombitzasabine firstcaseofpostmortemstudyinapatientvaccinatedagainstsarscov2
AT tebbejohannesjosef firstcaseofpostmortemstudyinapatientvaccinatedagainstsarscov2
AT rockenchristoph firstcaseofpostmortemstudyinapatientvaccinatedagainstsarscov2
AT schulzbirte firstcaseofpostmortemstudyinapatientvaccinatedagainstsarscov2
AT weisemichael firstcaseofpostmortemstudyinapatientvaccinatedagainstsarscov2
AT wilkensludwig firstcaseofpostmortemstudyinapatientvaccinatedagainstsarscov2